Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 7 (3 (4 (6 fluorobenzo[d]isoxazol 3 yl)piperidin 1 yl)propoxy) 2 methyl 3,4 dihydroisoquinolin 1(2H) one. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113195454A reveals a novel synthesis route for Formula VI intermediates, offering superior purity over 99% and safer Lewis acid demethylation for scalable API manufacturing.